Home Research AG Minden

Minden group

Optimization of health care for young people with rheumatic diseases

Introduction
Members
Cooperation partners
Current Publications

Paediatric Rheumatology and Health services research

The group evaluates the health care situation and outcomes of children, adolescents, and young adults with inflammatory rheumatic diseases. Particular attention is paid to juvenile idiopathic arthritis (JIA).

In the National Paediatric Rheumatologic Database (NPRD), about 14,000 patients with juvenile rheumatic diseases are recorded annually from over 60 paediatric rheumatological centers. The group was able to show that adolescents with JIA have a higher disease burden and a higher risk for an inactive lifestyle, being overweight and having other comorbidities than children. The frequency of mental health problems in young people with JIA is currently being investigated by a short screener on the web-based platform KRhOKo as part of the interdisciplinary research network COACH. In cooperation with the diabetes and obesity register for young people, we also assess the burden of the coronavirus pandemic via the NPRD.

In the JIA inception cohort ICON, 975 JIA patients and almost 500 healthy peers have been observed for approximately 10 years now. The group could show that sociodemographic and clinical parameters such as age at disease onset, JIA category, higher family burden and especially the time between symptom onset and first visit to a rheumatologist predict the outcome of JIA. In addition, we found an inverse correlation of the 25(OH)-vitamin D serum level with the risk of uveitis and a polyarticular-course of JIA.

The Juvenile arthritis Methotrexate/Biologics long-term Observation (JuMBO) is the follow-up register of the national JIA biologic register BiKeR, in which more than 1,700 JIA patients are currently being observed from DMARD start in childhood into adulthood. To date, no serious safety problems have been identified. Rather, we found that the earlier an effective DMARD therapy is started, the higher the chance of drug-free remission and full functional capability and the lower the damage to the joints in adulthood.

In close cooperation with the Deutsche Rheuma-Liga e.V., we develop and evaluate transition resources for young people with rheumatic diseases moving to adult care. According to NPRD data, transition readiness and disease-specific knowledge among young people with JIA are still suboptimal.

Further projects linked to the nationwide core documentation of children and adolescents with rheumatic diseases:

  • ProKind: Collection of additional information on therapy in the first year of treatment with the aim of further improving the treatment of children and adolescents with rheumatic diseases
  • COACH: Chronic Conditions in Adolescents: Implementation and Evaluation of Patient-centred Collaborative Healthcare – Screening for mental health in adolescents with JIA
  • TARISMA: Targeted Risk Management in Musculoskeletal Diseases: Identification of health care pathways, patient groups at risk of undersupply, and development of patient-centred care strategies – Activity monitoring in adolescents and young adults with inflammatory rheumatic musculoskeletal diseases (ActiMON)
  • Kick COVID: Collaborative project to assess the impact of the coronavirus pandemic on children and adolescents with rheumatic diseases and their families.

Close cooperation with many pediatric and adult rheumatological departments and ophthalmological units is the basis for the successful conduction of the observational studies.

 

Paediatric Rheumatology Prof. Dr. med. Kirsten Minden Phone +49 (0)30 28460-669 minden@drfz.de more
Partner der Charité Versorgungsforschung
Continue to Members

Group leader
Prof. Dr. med. Kirsten Minden

Scientists
Martina Niewerth MPH
Dr. med. Claudia Sengler
PD Dr. rer. nat. Jens Klotsche
Dr. rer. medic. Florian Milatz
Dipl.-Math. Sascha Eulert

Data manager
Dipl.-Stat. Ina Liedmann
Cornelia Stamme-Schäfer
Jana Hörstermann BA
Nadine Grösch
Anneli Rieck

MD students
Sabine Kirchner
Nina Brüggemann
Nadine Betenstehl
Laura Montag
Juliane Rieß
Henriette Haney

Students
Nina Biernacka
Juliane Lenz
Inga Stüdemann
Nane Stüdemann
Jasmin Ahmad
Theresia Giersdorf
Robyn Kettlitz

Partner der Charité Versorgungsforschung
Continue to Cooperation partners

Approximately 430 rheumatological centers of all levels of care throughout Germany and parts of Austria, Poland and Russia participate in JUMBO, ICON and the National Paediatric Rheumatologic Database.

  • Prof. Dr. Gerd Horneff, Asklepios Kinderklinik Sankt Augustin
  • PD Dr. Tilmann Kallinich, Universitätsmedizin Charité – Berlin
  • Prof. Dr. Dirk Foell, Universitätsklinikum Münster
  • Prof. Dr. Johannes-Peter Haas, Deutsches Zentrum für Kinder- und Jugendrheumatologie, Garmisch Partenkirchen
  • PD Dr. Daniel Windschall, St. Josef-Stift, Sendenhorst
  • Frank Weller, Klinikum Bremen-Mitte
  • Dr. Anton Hospach, Klinikum Stuttgart
  • Dr. Kirsten Mönkemöller, Kinderkrankenhaus der Stadt Köln
  • Dr. Frank Dressler, Medizinische Hochschule Hannover
  • Prof. Dr. Jasmin Kümmerle-Deschner, Universitätsklinikum Tübingen
  • Dr. Ivan Foeldvari, Kinderrheumatologische Praxis am AK Eilbek, Hamburg
  • Prof. Dr. Klaus Tenbrock, Klinikum der RWTH Aachen

And over 50 other paediatric as well as more than 250 adult rheumatologists:

  • Prof. Dr. Arnd Heiligenhaus, Augenabteilung am St. Franziskus Hospital, Münster
  • Prof. Dr. Christoph Tappeiner, Universitätsklinik für Augenheilkunde, Bern, Schweiz and more than 200 ophthalmological sites
  • Dr. Heinrike Schmeling, University of Calgary, Canada – ICON cohort: Autoantibody analysis
  • Prof. Dr. Nico Wulffraat, Wilhelmina Ziekenhuis, Utrecht, Niederlande / Prof. Dr. Kimme Hyrich, The University of Manchester, United Kingdom / Prof. Dr. Nicola Ruperto, University of Genoa, Italy – Comorbidities in juvenile idiopathic Arthritis
  • Prof. Dr. Harald Baumeister, Universität Ulm / Prof. Dr. Reinhard W. Holl, Universität Ulm / Prof. Dr. Petra Warschburger, Universität Potsdam / Prof. Dr. Thomas Meissner, Universität Düsseldorf – Chronic Conditions in Adolescents: Implementation and Evaluation of Patient-centred Collaborative Healthcare (COACH)
  • Prof. Dr. Reinhard W. Holl, Universität Ulm / Prof. Dr. Petra Warschburger, Universität Potsdam (Kick COVID)
  • Prof. Dr. Burkhard Tönshoff / Prof. Dr. Petra Knaup, Universitätsklinikum Heidelberg – Kinderrheumatologie Online – Kerndokumentation (KRhOKo)
Partner der Charité Versorgungsforschung
Continue to Current Publications
  • Klotsche J, Klein A, Niewerth M, Hoff P, Windschall D, Foeldvari I, Haas JP, Horneff G, Minden K. Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis. Arthritis Res Ther. 2021 Apr 16;23(1):118.
  • Minden K, Klotsche J. Transition Between Treatments: What We Need to Know. J Rheumatol. 2021 Apr 15:jrheum.201331.
  • Heinrich-Rohr M, Mönkemöller K, Niewerth M, Sengler C, Liedmann I, Kallinich T, Horneff G, Windschall D, Haas JP, Dressler F, Foeldvari I, Weller-Heinemann F, Hospach T, Kuemmerle-Deschner J, Föll D, Klotsche J, Minden K. Consumer perspective on healthcare services for juvenile idiopathic arthritis: results of a multicentre JIA inception cohort study. Clin Exp Rheumatol. 2021 Mar 30. Online ahead of print.
  • Horn S, Minden K, Speth F, Schwarz T, Dressler F, Grösch N, Haas JP, Hinze C, Horneff G, Hospach A, Kallinich T, Klotsche J, Köstner K, Meisel C, Niewerth M, Oommen PT, Schütz C, Weller-Heinemann F, Unterwalder N, Sengler C. Myositis-specific autoantibodies and their associated phenotypes in juvenile dermatomyositis: data from a German cohort. Clin Exp Rheumatol. 2020 Oct 29. Online ahead of print.
  • Walscheid K, Glandorf K, Rothaus K, Niewerth M, Klotsche J, Minden K, Heiligenhaus A. Enthesitis-related Arthritis: Prevalence and Complications of Associated Uveitis in Children and Adolescents From a Population-based Nationwide Study in Germany. J Rheumatol. 2021 Feb;48(2):262-269.
  • Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Terreri MT, Sakamoto AP, Stanevicha V, Sztajnbok F, Anton J, Feldman B, Alexeeva E, Katsicas M, Smith V, Avcin T, Marrani E, Kostik M, Lehman T, Sifuentes-Giraldo WA, Vasquez-Canizares N, Appenzeller S, Janarthanan M, Moll M, Nemcova D, Patwardhan A, Santos MJ, Sawhney S, Schonenberg-Meinema D, Battagliotti C, Berntson L, Bica B, Brunner J, Costa-Reis P, Eleftheriou D, Harel L, Horneff G, Kaiser D, Kallinich T, Lazarevic D, Minden K, Nielsen S, Nuruzzaman F, Uziel Y, Helmus N, Torok KS. Differences sustained between diffuse and limited forms of juvenile systemic sclerosis in expanded international cohort. juvenile-scleroderma.com. Arthritis Care Res (Hoboken). 2021 Mar 30.
  • Foeldvari I, Klotsche J, Hinrichs B, Helmus N, Kasapcopur O, Adrovic A, Sztajnbok F, Terreri MT, Anton J, Smith V, Katsicas M, Kostik M, Vasquez-Canizares N, Avcin T, Feldman B, Janarthanan M, Santos MJ, Sawhney S, Schonenberg-Meinema D, Sifuentes-Giraldo WA, Alexeeva E, Appenzeller S, Battagliotti C, Berntson L, Bica B, Costa Reis P, Eleftheriou D, Kallinich T, Lehman T, Marrani E, Minden K, Nielsen S, Nuruzzaman F, Patwardhan A, Khubchandani R, Stanevicha V, Uziel Y, Torok KS. Under detection of interstitial lung disease in juvenile systemic sclerosis (jSSc). Arthritis Care Res (Hoboken). 2020 Nov 3.
  • Geirhos A, Lunkenheimer F, Holl RW, Minden K, Schmitt A, Temming S, Baumeister H, Domhardt M. Involving patients’ perspective in the development of an internet- and mobile-based CBT intervention for adolescents with chronic medical conditions: Findings from a qualitative study. Internet Interv. 2021 Mar 16;24:100383.
  • Ganeva M, Fuehner S, Kessel C, Klotsche J, Niewerth M, Minden K, Foell D, Hinze CH, Wittkowski H. Trajectories of disease courses in the inception cohort of newly diagnosed patients with JIA (ICON-JIA): the potential of serum biomarkers at baseline. Pediatr Rheumatol Online J. 2021 May 1;19(1):64.
  • Thiele F, Klein A, Windschall D, Hospach A, Foeldvari I, Minden K, Weller-Heinemann F, Horneff G. Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry. Rheumatol Int. 2021 Apr;41(4):751-762.
  • Albrecht K, Milatz F, Callhoff J, Redeker I, Minden K, Strangfeld A, Regierer A. [Perspectives for rheumatological health services research at the German Rheumatism Research Center]. Z Rheumatol. 2020 Dec;79(10):1003-1008.
  • Meißner Y, Milatz F, Callhoff J, Minden K, Regierer A, Strangfeld A. [Register and cohort studies : Overview of the most important data sources at the German Rheumatism Research Center]. Z Rheumatol. 2020 Dec;79(10):983-995.
  • Janda A, Schuetz C, Canna S, Gorelik M, Heeg M, Minden K, Hinze C, Schulz A, Debatin KM, Hedrich CM, Speth F. Therapeutic approaches to pediatric COVID-19: an online survey of pediatric rheumatologists. Rheumatol Int. 2021 May;41(5):911-920.
  • Thiele F, Klein A, Windschall D, Hospach A, Foeldvari I, Minden K, Weller-Heinemann F, Horneff G. Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry. Rheumatol Int. 2021 Apr;41(4):751-762.
  • Minden K. How to close the gap between paediatric and adult care. Nat Rev Rheumatol. 2021 Jan;17(1):9-10.
  • Papa R, Lane T, Minden K, Touitou I, Cantarini L, Cattalini M, Obici L, Jansson AF, Belot A, Frenkel J, Anton J, Wolska-Kusnierz B, Berendes R, Remesal A, Jelusic M, Hoppenreijs E, Espada G, Nikishina I, Maggio MC, Bovis F, Masini M, Youngstein T, Rezk T, Papadopoulou C, Brogan PA, Hawkins PN, Woo P, Ruperto N, Gattorno M, Lachmann HJ; Pediatric Rheumatology International Trials Organization (PRINTO), the EUROTRAPS, and the Eurofever Project. INSAID Variant Classification and Eurofever Criteria Guide Optimal Treatment Strategy in Patients with TRAPS: Data from the Eurofever Registry. J Allergy Clin Immunol Pract. 2021 Feb;9(2):783-791.e4.
  • Walscheid K, Klotsche J, Tappeiner C, Niewerth M, Foell D, Minden K, Heiligenhaus A. Adherence to ophthalmological screening recommendations and course of uveitis in children with juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with JIA (ICON-JIA) study. Clin Exp Rheumatol. 2020 Jul-Aug;38(4):792-798.
Partner der Charité Versorgungsforschung
Continue to Introduction
Print
Share
Sign up for the
DRFZ NewsFlash